HARP — Harpoon Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $492.35m
- $469.57m
- $31.92m
Annual cashflow statement for Harpoon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.4 | -55.6 | -49.9 | -117 | -67.7 |
| Depreciation | |||||
| Non-Cash Items | 0.672 | 2.73 | 5.78 | 12.3 | 9.77 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.08 | 49 | 33.4 | -19.9 | -33.6 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -27.1 | -2.89 | -8.62 | -122 | -89.2 |
| Capital Expenditures | -0.663 | -3.52 | -0.683 | -0.1 | -0.347 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -65.8 | -62.9 | 34.5 | 90.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.663 | -69.3 | -63.6 | 34.4 | 89.7 |
| Financing Cash Flow Items | -1.66 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 88.3 | 71.4 | 4.68 | 112 | 6.37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 60.5 | -0.757 | -67.6 | 23.7 | 6.93 |